Characterization of Redox-Responsive LXR-Activating Nanoparticle Formulations in Primary Mouse Macrophages
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Characterization of Redox-Responsive LXR-Activating Nanoparticle Formulations in Primary Mouse Macrophages
Authors
Keywords
-
Journal
MOLECULES
Volume 24, Issue 20, Pages 3751
Publisher
MDPI AG
Online
2019-10-18
DOI
10.3390/molecules24203751
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Delivery of microRNAs by Chitosan Nanoparticles to Functionally Alter Macrophage Cholesterol Efflux In Vitro and In Vivo
- (2019) My-Anh Nguyen et al. ACS Nano
- Co-Targeting Bulk Tumor and CSCs in Clinically Translatable TNBC Patient-Derived Xenografts via Combination Nanotherapy
- (2019) Andrew Sulaiman et al. MOLECULAR CANCER THERAPEUTICS
- Imaging-assisted nanoimmunotherapy for atherosclerosis in multiple species
- (2019) Tina Binderup et al. Science Translational Medicine
- Glutathione-Scavenging Poly(disulfide amide) Nanoparticles for the Effective Delivery of Pt(IV) Prodrugs and Reversal of Cisplatin Resistance
- (2018) Xiang Ling et al. NANO LETTERS
- Neutrophil membrane-coated nanoparticles inhibit synovial inflammation and alleviate joint damage in inflammatory arthritis
- (2018) Qiangzhe Zhang et al. Nature Nanotechnology
- PLA-PEG Nanoparticles Improve the Anti-Inflammatory Effect of Rosiglitazone on Macrophages by Enhancing Drug Uptake Compared to Free Rosiglitazone
- (2018) Giovanna Giacalone et al. Materials
- Tiny Things with Enormous Impact: Nanotechnology in the Fight Against Infectious Disease
- (2018) Stephanie L. Mitchell et al. ACS Infectious Diseases
- Glutathione responsive polymers and their application in drug delivery systems
- (2017) John F. Quinn et al. Polymer Chemistry
- Targeted Nanotherapeutics Encapsulating Liver X Receptor Agonist GW3965 Enhance Antiatherogenic Effects without Adverse Effects on Hepatic Lipid Metabolism in Ldlr−/− Mice
- (2017) Mikyung Yu et al. Advanced Healthcare Materials
- Targeted Interleukin-10 Nanotherapeutics Developed with a Microfluidic Chip Enhance Resolution of Inflammation in Advanced Atherosclerosis
- (2016) Nazila Kamaly et al. ACS Nano
- Pioglitazone-Incorporated Nanoparticles Prevent Plaque Destabilization and Rupture by Regulating Monocyte/Macrophage Differentiation inApoE−/−MiceSignificance
- (2016) Soichi Nakashiro et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Quantitative Profiling of Protein S-Glutathionylation Reveals Redox-Dependent Regulation of Macrophage Function during Nanoparticle-Induced Oxidative Stress
- (2015) Jicheng Duan et al. ACS Nano
- Redox-Responsive Polymer–Drug Conjugates Based on Doxorubicin and Chitosan Oligosaccharide-g-stearic Acid for Cancer Therapy
- (2015) Yigang Su et al. MOLECULAR PHARMACEUTICS
- Targeted nanoparticles containing the proresolving peptide Ac2-26 protect against advanced atherosclerosis in hypercholesterolemic mice
- (2015) Gabrielle Fredman et al. Science Translational Medicine
- Predicting therapeutic nanomedicine efficacy using a companion magnetic resonance imaging nanoparticle
- (2015) Miles A. Miller et al. Science Translational Medicine
- Multi-drug delivery nanocarriers for combination therapy
- (2015) Suresh Gadde MedChemComm
- Development of Therapeutic Polymeric Nanoparticles for the Resolution of Inflammation
- (2014) Suresh Gadde et al. Advanced Healthcare Materials
- Nanoparticles Containing a Liver X Receptor Agonist Inhibit Inflammation and Atherosclerosis
- (2014) Xue-Qing Zhang et al. Advanced Healthcare Materials
- Stimuli-responsive cross-linked micelles for on-demand drug delivery against cancers
- (2013) Yuanpei Li et al. ADVANCED DRUG DELIVERY REVIEWS
- Reciprocal Regulation of Hepatic and Adipose Lipogenesis by Liver X Receptors in Obesity and Insulin Resistance
- (2013) Simon W. Beaven et al. Cell Metabolism
- Stimuli-responsive nanocarriers for drug delivery
- (2013) Simona Mura et al. NATURE MATERIALS
- Development and in vivo efficacy of targeted polymeric inflammation-resolving nanoparticles
- (2013) N. Kamaly et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeted polymeric therapeutic nanoparticles: design, development and clinical translation
- (2012) Nazila Kamaly et al. CHEMICAL SOCIETY REVIEWS
- Transcriptional integration of metabolism by the nuclear sterol-activated receptors LXR and FXR
- (2012) Anna C. Calkin et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- pH and Reduction Dual-Sensitive Copolymeric Micelles for Intracellular Doxorubicin Delivery
- (2011) Jun Chen et al. BIOMACROMOLECULES
- Hematopoietic AMPK β1 reduces mouse adipose tissue macrophage inflammation and insulin resistance in obesity
- (2011) Sandra Galic et al. JOURNAL OF CLINICAL INVESTIGATION
- LXR promotes the maximal egress of monocyte-derived cells from mouse aortic plaques during atherosclerosis regression
- (2010) Jonathan E. Feig et al. JOURNAL OF CLINICAL INVESTIGATION
- LXR Signaling Couples Sterol Metabolism to Proliferation in the Acquired Immune Response
- (2008) Steven J. Bensinger et al. CELL
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started